12
Participants
Start Date
October 31, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
Mouse Allergenic Extract
Subjects will receive escalating doses of glycerinated mouse allergenic extract administered subcutaneously up to a maximum study dose (MSD) of 0.4 mL of extract at a concentration of 1:10 wt/vol., per protocol.
Children's National Health System, Washington D.C.
Johns Hopkins Children's Center: Department of Allergy & Immunology, Baltimore
Henry Ford Health System: Division of Allergy and Immunology, Detroit
Ann and Robert Lurie Children's Hospital of Chicago, Chicago
Inner-City Asthma Consortium
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH